相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduction in late mortality among 5-year survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Gregory F. Guzauskas et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2017)
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Munster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen
Michael E. Rytting et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group
Rob Pieters et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
Nathalie Dhedin et al.
BLOOD (2015)
Influence of Insurance and Marital Status on Outcomes of Adolescents and Young Adults With Acute Lymphoblastic Leukemia
Andrew E. Fintel et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
Wasil Jastaniah et al.
HEMATOLOGY (2015)
Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia
D. J. DeAngelo et al.
LEUKEMIA (2015)
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers
Inci Alacacioglu et al.
CHEMOTHERAPY (2014)
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
Smita Bhatia et al.
BLOOD (2014)
Augmented Berlin-Frankfurt-Munster Therapy in Adolescents and Young Adults (AYAs) With Acute Lymphoblastic Leukemia (ALL)
Michael E. Rytting et al.
CANCER (2014)
Prevalence of being underweight and overweight and obesity at diagnosis in UK patients with childhood acute lymphoblastic leukaemia 1985-2002
F. K. Aldhafiri et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2014)
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
C. J. Harrison et al.
LEUKEMIA (2014)
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
K. R. Schultz et al.
LEUKEMIA (2014)
Ph-like Acute Lymphoblastic Leukemia in Older Adults
Tobias Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group
F. Hayakawa et al.
BLOOD CANCER JOURNAL (2014)
Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis
Vikas Gupta et al.
BLOOD (2013)
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL
Arian van der Veer et al.
BLOOD (2013)
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia Results of cancer and leukemia group B study 19802
Wendy Stock et al.
CANCER (2013)
Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group
Nyla A. Heerema et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts et al.
CANCER CELL (2012)
Advances in the Genetics of High-Risk Childhood B-Progenitor Acute Lymphoblastic Leukemia and Juvenile Myelomonocytic Leukemia: Implications for Therapy
Mignon L. Loh et al.
CLINICAL CANCER RESEARCH (2012)
Children, Adolescents, and Young Adults With Leukemia: The Empty Half of the Glass Is Growing
Archie Bleyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881
Nicolas Sirvent et al.
EUROPEAN JOURNAL OF CANCER (2011)
Unique Characteristics of Adolescent and Young Adult Acute Lymphoblastic Leukemia, Breast Cancer, and Colon Cancer
James V. Tricoli et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: a single institution experience
Guillermo J. Ruiz-Delgado et al.
LEUKEMIA & LYMPHOMA (2011)
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
Wendy Stock et al.
LEUKEMIA & LYMPHOMA (2011)
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
Richard C. Harvey et al.
BLOOD (2010)
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
Farhad Ravandi et al.
BLOOD (2010)
Potential Favorable Impact of the Affordable Care Act of 2010 on Cancer in Young Adults in the United States
W. Archie Bleyer
CANCER JOURNAL (2010)
Review of Adherence-Related Issues in Adolescents and Young Adults With Cancer
Phyllis Butow et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group
W. L. Salzer et al.
LEUKEMIA (2010)
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)
L. B. Silverman et al.
LEUKEMIA (2010)
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia
C. H. Pui et al.
LEUKEMIA (2010)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A. Moericke et al.
LEUKEMIA (2010)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
V. Conter et al.
LEUKEMIA (2010)
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report
P. S. Gaynon et al.
LEUKEMIA (2010)
The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse
K. Schmiegelow et al.
LEUKEMIA (2010)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Lisa J. Russell et al.
BLOOD (2009)
Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia
Christine J. Harrison
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
Monique L. Den Boer et al.
LANCET ONCOLOGY (2009)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Acute lymphoblastic leukemia in adolescents and young adults in Finland
Anu Usvasalo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Obesity and outcome in pediatric acute lymphoblastic leukemia
Anna M. Butturini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler et al.
BLOOD (2007)
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Elly Barry et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2007)
Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden -: A comparison between a pediatric protocol and an adult protocol
Helene Hallbook et al.
CANCER (2006)
Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: Experience of the Dutch Childhood Oncology Group
D. Maroeska W. M. te Loo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia:: Data from the trials ALL-BFM 86, 90, and 95
A Möricke et al.
KLINISCHE PADIATRIE (2005)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
JM de Bont et al.
LEUKEMIA (2004)
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas et al.
BLOOD (2004)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia:: Significance of low leukocyte counts with blasts or traumatic lumbar puncture
B Bürger et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia
C Linker et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
LB Silverman et al.
BLOOD (2001)
Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994
KW Maloney et al.
LEUKEMIA (2000)
Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
